SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma Inc. reported in the October issue of “Cancer Chemotherapy and Pharmacology”*, a leading cancer journal, the final results of a Phase 1b cancer study ...
SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...
Randomized double-blind phase II trial comparing gemcitabine (GEM) plus LY293111 vs. GEM plus placebo in advanced adenocarcinoma of the pancreas ...
Phase I/II study of LipoCurc™ in glioblastoma accepted for poster presentation at ASCO 2025, in collaboration with Johns Hopkins. We’re encouraged by the study’s early momentum and the opportunity to ...
Over 200 scientific studies have concluded that curcumin has the propensity to avert prostate cancer. As a leading developer in liposomal science, MaxHealthLabs is dedicated to producing quality ...
Liposomal supplements use a unique delivery system to enhance the absorption of nutrients. Traditional vitamins and minerals are often broken down in the stomach before reaching the bloodstream, ...
Curcumin may help lower the levels of molecules that cause inflammation, such as cytokines and enzymes. This may help with arthritis, asthma, and inflammatory bowel disease. Curcumin may improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback